In December, 2021, AliveX Biotech has honored by Pharma Tech Outlook Magazine as the 2021 Top 10 Immunotherapy Solutions Providers in APAC. This award aims to recognize pioneer companies in the field which have excellent performance in technology, product, R&D and commercialization in immunotherapy in the APAC region. Meanwhile, Pharma Tech Outlook reached out to AliveX Chief Strategy Officer and Co-founder Dr. Dimitris Christodoulou in an exclusive magazine cover interview for his insights on AliveX's business and technology as well as on the biopharma industrial trends. This interview covers some interesting topics, such as how the company does this, the "human-based" data-driven biomarker discovery approach used in AliveX, the world-class interdisciplinary team AliveX assembled, and the company's goal to transform life science research. (Read more)